Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1

Journal of Immunology

Volumn 170, Issue 12, 2003, Pages 6183-6189

  Marshall, Neil A ^a   Vickers, Mark A ^a   Barker, Robert N ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CONCANAVALIN A; INTERLEUKIN 10; KEYHOLE LIMPET HEMOCYANIN; LATENT MEMBRANE PROTEIN 1; MITOGENIC AGENT; NEUTRALIZING ANTIBODY; PEPTIDE; RECALL ANTIGEN; TUBERCULIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DONOR; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LATENT PERIOD; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0038280092     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.12.6183     Document Type: Article

References (53)

1. Xu, X.-N., G. R. Screatom, and A. J. McMichael. 2001. Virus infections: escape, resistance, and counterattack. Immunity 15:867
2. Lorenzo, M. E., H. L. Ploegh, and R. S. Tirabassi. 2001. Viral immune evasion strategies and the underlying cell biology. Semin. Immunol. 13:1.
3. Erickson, A. L., Y. Kimura, S. Igarashi, J. Eichelberger, M. Houghton, J. Sidney, D. McKinney, A. Sette, A. L. Hughes, and C. M. Walker. 2001. The outcome of hepatitis C virus infection is predicted by escape mutation in epitopes targeted by cytotoxic T lymphocytes. Immunity 15:883.
4. + T cells. Immunity 15:871.
5. Rowe, M., R. Khanna, C. A. Jacob, V. Argaet, A. Kelly, S. Powis, M. Belich, D. Croom-Carter, S. Lee, S. R. Burrows, J. Trowsdale, D. J. Moss, and A. B. Rickinson. 1995. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur. J. Immunol. 25:1374.
6. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klien, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685.
7. Levitskaya, J., A. Sharipo, A. Leonchiks, A. Ciechanover, and M. G. Masucci. 1997. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA 94:12616
8. Kawanishi, M., S. Tada-Oikawa, and S. Kawanishi. 2002. Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells. Biochem. Biophys. Res. Commun. 297:682.
9. Fries, K. L., W. E. Miller, and N. Raab-Traub. 1996. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70:8653.
10. Kieff, E. 2001. Epstein-Barr virus and its replication. In Fields Virology. 4th Ed. D. M. Knipe and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, p. 2343.
11. Pallesen, G., S. J. Hamilton-Dutoit, M. Rowe, and L. S. Young. 1991. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320.
12. Tsao, S. W., G. Tramoutanis, C. W. Dawson, A. K. F. Lo, and D. P. Huang. 2002. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin. Cancer Biol. 12:473.
13. Eliopoulos, A. G., M. Stack, C. W. Dawson, K. M. Kaye, L. Hodgkin, S. Sihota, M. Rowe, and L. S. Young. 1997. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelia[cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene 14:2899.
14. Huen, D. S., S. A. Henderson, D. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549.
15. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389.
16. Young, L. S., A. G. Eliopoulos, N. J. Gallagher, and C. W. Dawson. 1998. CD40 and epithelial cells: across the great divide. Immunol. Today 19:502.
17. + T cells precipitates immunopathology in immunodeficient mice infected with a noncytocidal virus. J. Immunol. 166:3384.
18. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
19. Levings, M. K., and M. G. Roncarolo. 2000. T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J. Allergy Clin. Immunol. 106:S109.
20. Roncarolo, M., and M. K. Levings. 2000. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12:676.
21. - subpopulations. J. Immunol. 165:3105.
22. Mossman, T. R., and R. L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T-cells. Adv. Immunol. 46:111.
23. Gorelik. L., and R. A. Flavell. 2000. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12:171.
24. Weiner, H. L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18:335.
25. Seddon, B., and D. Mason. 2000. The third function of the thymus. Immunol. Today 21:95.
26. Shevach, E. M. 2000. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:423.
27. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285.
28. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295.
29. McGuirk, P., C. McCann, and K. H. G. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221.
30. Zuany-Amorim, C., E. Sawicka, C. Manlius, A. Le Moine, L. R. Brunet, D. M. Kemeny, G. Bowen, G. Rooke, and C. Walker. 2002. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8:625.
31. MacDonald, A. J., M. Duffy, M. T. Brady, S. McKiernan, W. Hall, J. Hegarty, M. Curry, and K. H. G. Mills. 2002. CD4 helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185:720.
32. + T cells from Epstein-Barr virus (EBV) seropositive donors. Clin. Exp. Immunol. 126:101.
33. + malignancies. J. Exp. Med. 176:157
34. Khanna, R., S. R. Burrows, J. Nicholls, and L.M. Poulsen. 1998. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur. J. Immunol. 28:451.
35. Hawke, S., N. Willcox, G. Harcourt, A. Vincent, and J. Newsom-Davis. 1992. Stimulation of human T cells by sparse antigens captured on immunomagnetic particles. J. Immunol. Methods 155:41.
36. Barker, R. N., A. J. Easterfield, R. F. Allen, A. D. Wells, C. J. Elson, and S. J. Thompson. 1996. B and T-cell autoantigens in pristane-induced arthritis. Immunology 8:189.
37. Barker, R. N., G. G. de Sá Oliveira, C. J. Elson, and P. M. Lydyard. 1993. Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte Band 3 protein. Eur. J. Immunol. 23:1723.
38. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207.
39. Stott, L. M., R. N. Barker, and S. J. Urbaniak. 2000. Identification of alloreactive T-cell epitopes on the rhesus D protein. Blood 96:4011.
40. Plebanski, M., M. Saunders, S. S. Burtles, S. Crowe, and D. C. Hooper. 1992. Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms. Immunology 75:86.
41. Devereux, G., A. M. Hall, and R. N. Barker. 2000. Measurement of T-helper cytokines secreted by cord blood mononuclear cells in response to allergens. J. Immunol. Methods 234:13.
42. Seglen, P. O., B. Grinde, and A. E. Solheim. 1979. Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. Eur. J. Biochem. 95:215.
43. Picker, L. J., M. K. Singh, Z. Zdraveski, J. R. Treer, S. L. Waldrop, P. R. Bergstresser, and V. C. Maino. 1995. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86:1408.
44. Mills, K. H. G., O. Leavy, P. McGuirk, S. Higgins, E. McNeela, C. McCann, M. E. Armstrong, and E. Lavelle. 2002. Pathogen-derived immunomodulatory molecules: the bridge between innate and adaptive immunity. Immunology 107(Suppl. 1):8.
45. Urban, B. C., N. Willcox, and D. J. Roberts. 2001. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA 98:8750.
46. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
47. Dukers, D. F., P. Meij, M. B. Vervoort, W. Vos, R. J. Scheper, C. J. Meijer, E. Bloemena, and J. M. Middeldorp. 2000. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunol. 165:663.
48. Hall, A. M., F. J. Ward, M. A. Vickers, L.-M. Stott, S. J. Urbaniak, and R. N. Barker. 2002. Interleukin-10 mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood 100:4529.
49. Hayes, D. P., A. A. Brink, M. B. Vervoort, J. M. Middeldorp, C. J. Meijer, and A. J. van den Brule. 1999. Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. Mol. Pathol. 52:97.
50. + lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J. Exp. Med. 191:1649.
51. + T helper 1 responses. J. Virol. 75:8649.
52. De Campos-Lima, P. O., S. Torsteindottir, L. Cuomo, G. Klein, D. Sulitzeanu, and M. G. Masucci. 1993. Antigen processing and presentation by EBV-carrying cell lines: cell-phenotype dependence and influence of the EBV-encoded LMP1. Int. J. Cancer 53:856.
53. Spencer, J. V., K. M. Lockridge, P. A. Barry, G. Lin, M. Tsang, M. E. T. Penfold, and T. J. Schall. 2002. Potent immunosuppressive activities of cytomegalovirus encoded interleukin-10. J. Virol. 76:1285.